J. Landman-Parker

A. Baruchel, G. Leverger, K. Yakouben, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit – multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group

A. Baruchel, G. Leverger, T. Leblanc, 2005, Leukemia.

Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

A. Baruchel, G. Leverger, T. Leblanc, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of TCR, pT (cid:1)(cid:1)(cid:1)(cid:1) and RAG-1 in T Acute Lymphoblastic Leukemias improves understanding of early human T lymphoid lineage commitment.

E. Macintyre, F. Davi, P. Quartier, 2002 .

Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT

T. Leblanc, F. Montravers, J. Landman-Parker, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children

A. Baruchel, G. Leverger, T. Leblanc, 2007, Leukemia.

Treatment of childhood autoimmune haemolytic anaemia with rituximab

A. Fischer, P. Quartier, J. Landman-Parker, 2001, The Lancet.

Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.

P. Kearns, C. Zwaan, A. Place, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines

T. Leblanc, L. Claude, O. Oberlin, 2016, Pediatric hematology and oncology.

Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia

G. Leverger, M. Labopin, C. Preudhomme, 2010, Leukemia.

Simultaneous SIL‐TAL1 RT‐PCR detection of all tald deletions and identification of novel tald variants

E. Macintyre, F. Davi, E. Delabesse, 1997, British journal of haematology.

Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.

F. Rieux-Laucat, A. Fischer, C. Picard, 2018, Clinical immunology.

Outcome of relapse in children and adolescents with B‐cell non‐Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study

T. Leblanc, C. Patte, A. Aupérin, 2019, Pediatric blood & cancer.

Simplified strategies for minimal residual disease detection in B‐cell precursor acute lymphoblastic leukaemia

G. Leverger, E. Macintyre, C. Dollfus, 1996, British journal of haematology.

Efficacy of Tyrosine Kinase Inhibitors in Ph-like Acute Lymphoblastic Leukemia harboring ABL-class Rearrangements.

J. Soulier, E. Clappier, H. Dombret, 2019, Blood.

Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia

J. Landman-Parker, M. Tabone, A. Auvrignon, 2011, American journal of hematology.

Abatacept is useful in auto-immune cytopenia with immunopathologic manifestations caused by CTLA-4 defects.

F. Rieux-Laucat, C. Picard, G. Leverger, 2021, Blood.

Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations

J. Soulier, E. Clappier, A. Baruchel, 2011, Leukemia.

non-T-cell- depleted bone marrow transplantation frequent survival of residual recipient multipotent progenitors after Highly sensitive polymerase chain reaction methods show the

J. Bourhis, G. Socié, E. Gluckman, 2011 .

In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.

A. Fischer, A. Baruchel, E. Haddad, 1997, Leukemia & lymphoma.

Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 Patients

T. Leblanc, A. Leruste, J. Landman-Parker, 2021, Journal of pediatric hematology/oncology.

[Disseminated fusarium infection in two neutropenic children].

J. Landman-Parker, M. Tabone, A. Auvrignon, 2005, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia

C. Deswarte, E. Pasmant, I. Laurendeau, 2014, Oncogene.

SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype

E. Pasmant, A. Sabbagh, M. Vidaud, 2009, Journal of Medical Genetics.

Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome

F. Sigaux, J. Cayuela, A. Baruchel, 2008, Haematologica.

Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

R. Foà, P. Kearns, C. Zwaan, 2019, Clinical Cancer Research.

NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity.

H. Dombret, A. Baruchel, P. Romeo, 2009, Blood.

Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment.

E. Macintyre, F. Davi, P. Quartier, 2003, Blood.

Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)

A. Baruchel, G. Leverger, C. Hill, 2000, British Journal of Cancer.

Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.

A. Baruchel, G. Leverger, T. Leblanc, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables

A. Baruchel, G. Leverger, T. Leblanc, 1998, British journal of haematology.

associated with poor prognosis HOX11L2 expression defines a clinical subtype of pediatric T-ALL

J. Zucman‐Rossi, R. Berger, L. Ballerini, 2013 .

HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.

J. Zucman‐Rossi, R. Berger, O. Bernard, 2002, Blood.

HOX 11 L 2 expression defines a clinical subtype of pediatric TALL associated with poor prognosis

J. Zucman‐Rossi, R. Berger, O. Bernard, 2002 .

Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia.

A. Baruchel, C. Deswarte, S. Spicuglia, 2017, Blood advances.

NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance

P. Marynen, R. Berger, O. Bernard, 2005, Leukemia.

A phase II trial of partially incompatible bone marrow transplantation for high‐risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti‐LFA‐1 and anti‐CD2 antibodies

A. Baruchel, M. Cavazzana‐Calvo, B. Lacour, 1996 .

Diagnostic Applications of Nuclear Medicine: Pediatric Cancers

A. Ciarmiello, F. Montravers, T. Pfluger, 2016 .

WNT/β‐catenin pathway activation in Wilms tumors: A unifying mechanism with multiple entries?

Gudrun Schleiermacher, Liliane Boccon-Gibod, Aurélien de Reyniès, 2009, Genes, chromosomes & cancer.

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models

D. Gautheret, W. Vainchenker, O. Bernard, 2012, The Journal of experimental medicine.

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.

J. Soulier, J. Cayuela, A. Baruchel, 2018, Blood.

Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity

I. Bernstein, H. Dombret, A. Baruchel, 2010, Leukemia.

Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia.

A. Baruchel, M. Arcangeli, B. Colsch, 2017, Blood advances.

IL10RA Modulates Crizotinib Sensitivity in NPM1-ALK-positive Anaplastic Large Cell Lymphoma.

W. Klapper, B. Geoerger, G. Vassal, 2020, Blood.

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

T. Choueiri, M. Voss, S. George, 2018, Journal of Immunotherapy for Cancer.

Surgery in the treatment of nephroblastomatosis - a series of 19 patients

C. Patte, C. Bergeron, G. Schleiermacher, 2007 .

Neurological Involvement in Childhood Evans Syndrome

F. Rieux-Laucat, P. Varlet, G. Leverger, 2019, Journal of Clinical Immunology.

Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor.

O. Delattre, M. Peter, G. Schleiermacher, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survival of renal graft complicated with Burkitt lymphoma

G. Deschênes, J. Landman-Parker, S. Nathanson, 2002, Pediatric Nephrology.

Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies.

D. Frappaz, B. Geoerger, G. Vassal, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).

A. Baruchel, G. Leverger, T. Leblanc, 1996, Bone marrow transplantation.

Systematic review of phase‐I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research

M. Toulmonde, G. Vassal, S. Dumont, 2021, Cancer medicine.

Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group

N. Heerema, J. Harbott, O. Haas, 2000, Leukemia.

Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?

G. Leverger, C. Dosquet, M. Benbunan, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis

A. Baruchel, V. Baud, F. Pflumio, 2014, Leukemia.

In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma.

R. Döffinger, J. Casanova, J. Emile, 2000, The Journal of clinical investigation.

Partial engraftment of donor bone marrow cells associated with long‐term remission of haemophagocytic lymphohistiocytosis

A. Fischer, O. Brison, J. Landman-Parker, 1993, British journal of haematology.

Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non−T-cell−depleted bone marrow transplantation

J. Bourhis, G. Socié, E. Gluckman, 1994 .

Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantation.

J. Bourhis, G. Socié, E. Gluckman, 1994, Blood.

Human immunodeficiency virus-associated hemophagocytic syndrome in children.

C. Dollfus, J. Dalle, J. Landman-Parker, 1994, The Pediatric infectious disease journal.

SPRED1 disorder and predisposition to leukemia in children.

G. Leverger, D. Vidaud, P. Ballerini, 2009, Blood.

Detection of recipient cells after non T-cell depleted bone marrow transplantation for leukemia by PCR amplification of minisatellites or of a Y chromosome marker has a different prognostic value.

J. Bourhis, G. Socié, B. Raynal, 1994, Leukemia.

The majority of myeloid‐antigen‐positive (My+) childhood B‐cell precursor acute lymphoblastic leukaemias express TEL‐AML1 fusion transcripts

F. Sigaux, A. Baruchel, E. Macintyre, 1997, British journal of haematology.

Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy

A. Baruchel, O. Hermine, V. Asnafi, 2006, Leukemia.

Mutations in NALP12 cause hereditary periodic fever syndromes

S. Marlin, E. Alnemri, T. Fernandes-Alnemri, 2008, Proceedings of the National Academy of Sciences.

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression

A. Baruchel, J. Gross, C. Deswarte, 2014, EMBO molecular medicine.

Acute lymphoblastic leukemia and cutaneous mastocytosis in two children

C. Deswarte, P. Ballerini, J. Landman-Parker, 2008, Pediatric blood & cancer.

Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours.

D. Frappaz, A. Paci, B. Geoerger, 2010, European Journal of Cancer.

Acute Myeloid Leukemia (AML) in Children: Results of the French Trials

A. Baruchel, G. Leverger, T. Leblanc, 2001 .

Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report.

D. Hasenclever, T. Leblanc, W. Wallace, 2012, European journal of cancer.

Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.

A. Huitema, A. Beishuizen, W. Woessmann, 2022, Haematologica.

Increased R isk o f S ystemic R elapses A ssociated W ith B one Marrow M icrometastasis a nd C irculating T umor C ells i n Localized E wing T umor

O. Delattre, M. Peter, G. Schleiermacher, 2003 .

Mucoepidermoid carcinoma of the parotid gland in a child previously treated for acute lymphoblastic leukemia

P. Josset, F. Boman, J. Landman-Parker, 2005, Pediatric blood & cancer.

A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection

R. Berger, L. Douay, T. Mercher, 2003, Leukemia.

qPET – a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma

D. Hasenclever, A. Attarbaschi, O. Sabri, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Prognostic Factors and Treatment in Pediatric Acute Myeloblastic Leukemia: French Trials

A. Baruchel, G. Leverger, T. Leblanc, 1997 .

Neurological Involvement in Childhood Evans Syndrome

F. Rieux-Laucat, P. Varlet, G. Leverger, 2019, Journal of Clinical Immunology.

Quantitation of human herpes virus 6 genome in children with acute lymphoblastic leukemia

G. Leverger, P. Schneider, J. Vannier, 2008, Journal of medical virology.

Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma

D. Hasenclever, B. Buerke, A. Attarbaschi, 2023, Pediatric blood & cancer.

disorder and predisposition to leukemia in children SPRED1

G. Leverger, D. Vidaud, P. Ballerini, 2016 .

Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.

D. Hasenclever, A. Attarbaschi, T. Leblanc, 2023, The Lancet. Oncology.

Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma – Authors' reply

D. Hasenclever, W. Wallace, R. Kluge, 2023, The Lancet Oncology.

DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity.

F. Rieux-Laucat, C. Bodemer, C. Picard, 2023, Blood.

The CALM–AF10 fusion is a rare event in acute megakaryoblastic leukemia

J. Bourquin, B. Bornhauser, P. Ballerini, 2007, Leukemia.

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

K. Neville, F. Locatelli, S. Daw, 2014 .

Phase 1/2 Study Of Brentuximab Vedotin In Pediatric Patients With Relapsed Or Refractory (R/R) Hodgkin Lymphoma (HL) Or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 Data For Brentuximab Vedotin 1.8 Mg/Kg In The HL Study Arm

K. Neville, S. Daw, Angelo Rosolen, 2013 .

Digital pathology in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: correlation with treatment response

D. Hasenclever, W. Wallace, D. Körholz, 2023, Blood Advances.